Add to ORKGMalignant mesothelioma (MM) is an aggressive cancer arising from mesothelial cells, mainly due to former asbestos expo-sure. Little is known about the microRNA (miRNA) expression of MM. miRNAs are small noncoding RNAs, which play an essential role in the regulation of gene expression. This study was carried out to analyze the miRNA expression profile of 17 MM samples using miRNA microarray. The analysis distinguished the overall miRNA expression profiles of tumor tissue and normal mesothelium. Differentially expressed miRNAs were found in tumor samples compared with normal sample. Twelve of them, let-7b*, miR-1228*, miR-195*, miR-30b*, miR-32*, miR-345, miR-483-3p, miR-584, miR-595, miR-615-3p
Malignant mesothelioma is an aggressive cancer refractory to current therapies, the incidence of whi...
Introduction:We investigated the ability of cell-free microRNAs (miRNAs) in plasma and serum to serv...
Malignant pleural mesothelioma is a rare tumor with a dismal prognosis, usually presenting with recu...
MicroRNAs (miRNAs) post-transcriptionally regulate the expression of target genes, and may behave as...
Background: Malignant mesothelioma is a fatal cancer of the mesothelial cells characterized by previ...
BackgroundMalignant pleural mesothelioma (MPM) is a rare but aggressive asbestos-related cancer that...
BACKGROUND: Malignant pleural mesothelioma (MPM) is a rare but aggressive asbestos-related cancer th...
Malignant pleural mesothelioma (MPM) is an aggressive human cancer and miRNAs can play a key role fo...
University of Technology Sydney. Faculty of Science.Malignant pleural mesothelioma (MPM), a relative...
Background: Malignant pleural mesothelioma (MPM) is a highly aggressive tumour first-line treated wi...
Malignant pleural mesothelioma (MPM) is a rare but aggressive tumor that originates in the pleura, i...
Abstract Objective Malignant mesothelioma is an aggressive cancer of the serous membranes. For the d...
Background: Improved detection methods for diagnosis of malignant pleural mesothelioma (MPM) are ess...
OBJECTIVE: to evaluate the diagnostic potential of a panel of microRNAs in plasma samples of patient...
Malignant pleural mesothelioma (MPM) is an aggressive cancer, related to asbestos exposure, which ha...
Malignant mesothelioma is an aggressive cancer refractory to current therapies, the incidence of whi...
Introduction:We investigated the ability of cell-free microRNAs (miRNAs) in plasma and serum to serv...
Malignant pleural mesothelioma is a rare tumor with a dismal prognosis, usually presenting with recu...
MicroRNAs (miRNAs) post-transcriptionally regulate the expression of target genes, and may behave as...
Background: Malignant mesothelioma is a fatal cancer of the mesothelial cells characterized by previ...
BackgroundMalignant pleural mesothelioma (MPM) is a rare but aggressive asbestos-related cancer that...
BACKGROUND: Malignant pleural mesothelioma (MPM) is a rare but aggressive asbestos-related cancer th...
Malignant pleural mesothelioma (MPM) is an aggressive human cancer and miRNAs can play a key role fo...
University of Technology Sydney. Faculty of Science.Malignant pleural mesothelioma (MPM), a relative...
Background: Malignant pleural mesothelioma (MPM) is a highly aggressive tumour first-line treated wi...
Malignant pleural mesothelioma (MPM) is a rare but aggressive tumor that originates in the pleura, i...
Abstract Objective Malignant mesothelioma is an aggressive cancer of the serous membranes. For the d...
Background: Improved detection methods for diagnosis of malignant pleural mesothelioma (MPM) are ess...
OBJECTIVE: to evaluate the diagnostic potential of a panel of microRNAs in plasma samples of patient...
Malignant pleural mesothelioma (MPM) is an aggressive cancer, related to asbestos exposure, which ha...
Malignant mesothelioma is an aggressive cancer refractory to current therapies, the incidence of whi...
Introduction:We investigated the ability of cell-free microRNAs (miRNAs) in plasma and serum to serv...
Malignant pleural mesothelioma is a rare tumor with a dismal prognosis, usually presenting with recu...